Market uncertainty should "peak" around the Wednesday tariff deadline, according to Evercore ISI. In a note this week, Julian ...

Evercore ISI notes that Vaxcyte (PCVX) missed four serotypes versus Prevnar20 in the “all-important” infant data, adding that an “imperfect ...

We recently published a list of 10 AI Stocks Dominating the News This Week. In this article, we are going to take a look at ...

Fintel reports that on March 31, 2025, Evercore ISI Group downgraded their outlook for ChargePoint Holdings (NYSE:CHPT) from ...

Evercore ISI analyst Javier Escalante reiterated a Buy rating on Kimberly Clark (KMB – Research Report) on March 28 and set a price target of ...

Amazon is reportedly planning on extending its Prime Day sale to four days. That's more in line with rivals who have launched ...

Lending service Klarna announced on Thursday it is partnering DoorDash to offer flexible payments for those purchasing food, ...

When major events—like new tariffs or government layoffs—happen rapidly, it can be challenging to know what impact they will ...

It seems like every day recently, something new lands in the news cycle—sometimes contradicting what was announced a few hours before. Tariffs are on. Now they’re off again. The nuclear safety ...

Microsoft Corp. shares have fallen recently along with other once-hot technology stocks in an unraveling of the artificial-intelligence trade — but Evercore ISI analysts aren’t sure that ...

Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses. Daryanani covers the Technology sector, focusing on stocks such as Apple ...

On Wednesday, Evercore ISI began coverage on Summit Therapeutics plc (NASDAQ:SMMT) shares, assigning an Outperform rating and setting a price target of $30.00. The $13.65 billion market cap company, ...